BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12410141)

  • 1. [A T3 cancer of the mid-rectum].
    Penna Ch
    J Chir (Paris); 2002 Sep; 139(4):228-30. PubMed ID: 12410141
    [No Abstract]   [Full Text] [Related]  

  • 2. [A small-sized cancer of the lower rectum].
    Penna C
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B165-7. PubMed ID: 12843954
    [No Abstract]   [Full Text] [Related]  

  • 3. Pre- and postoperative adjuvant therapy for locally advanced rectal cancer.
    McGartland LP; Mulcahy MF; Benson AB
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):806-14. PubMed ID: 16166957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer.
    Maretto I; Pomerri F; Pucciarelli S; Mescoli C; Belluco E; Burzi S; Rugge M; Muzzio PC; Nitti D
    Ann Surg Oncol; 2007 Feb; 14(2):455-61. PubMed ID: 17139456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
    Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
    Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Very late development of hepatic metastases].
    Corté H; Benoist S; Penna C
    J Chir (Paris); 2009 Aug; 146(4):423-30. PubMed ID: 19766997
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
    Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
    Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
    Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
    Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of rectal cancer in pregnant women].
    Pigeau H; Dupré PF; Benouna J; Classe JM; Pioud R; Mahé MA; Dravet F
    Bull Cancer; 2005 Nov; 92(11):953-8. PubMed ID: 16316829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
    Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in treatment of primary irresectable rectal cancer.
    Reerink O; Mulder NH; Szabo BG; Sluiter WJ; Wiggers T; Bongaerts AH; Hospers GA
    Colorectal Dis; 2004 Nov; 6(6):406-17. PubMed ID: 15521928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal cancer.
    Legoux JL; Lehur PA; Penna C; Calais G; Roseau G; Calan LD
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S43-2S51. PubMed ID: 17151562
    [No Abstract]   [Full Text] [Related]  

  • 14. Rectal cancer.
    Zampino MG; Labianca R; Beretta GD; Magni E; Gatta G; Leonardi MC; Chiappa A; Biffi R; de Braud F; Wils J
    Crit Rev Oncol Hematol; 2009 May; 70(2):160-82. PubMed ID: 19059790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current debates on rectal cancer].
    Lasser P
    Gastroenterol Clin Biol; 2002 May; 26(5 Suppl):B78-85. PubMed ID: 12068274
    [No Abstract]   [Full Text] [Related]  

  • 16. Rectal cancer at the crossroads: the dilemma of clinically staged T3, N0, M0 disease.
    Kachnic LA; Hong TS; Ryan DP
    J Clin Oncol; 2008 Jan; 26(3):350-1. PubMed ID: 18202407
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evolution of surgery for cancer of the anorectal junction].
    Prete F; Prete FP; Nitti P; De Luca R; Vincenti L
    Chir Ital; 2007; 59(6):763-70. PubMed ID: 18360980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy.
    Höcht S; Hammad R; Thiel HJ; Wiegel T; Siegmann A; Willner J; Wust P; Herrmann T; Eble M; Flentje M; Carstens D; Bottke D; Neumann P; Hinkelbein W
    Strahlenther Onkol; 2004 Jan; 180(1):15-20. PubMed ID: 14704840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant and adjuvant therapy for rectal cancer.
    Arnoletti JP; Bland KI
    Surg Oncol Clin N Am; 2006 Jan; 15(1):147-57. PubMed ID: 16389155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.